BOSTON — Curiox Biosystems, a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, is pleased to announce its collaboration with Dr. Marco Ruella, an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn), to support efforts in the development of next-generation cancer cell therapies. We are collaborating […]

Empowering researchers to spatially profile more than 500 proteins simultaneously in FFPE tissue using abcam’s IHC-validated immuno-oncology antibody portfolio Seattle — NanoString Technologies, a leading provider of life science tools for discovery and translational research, announced today the launch of the latest assay for the GeoMx® Digital Spatial Profiler (DSP). The GeoMx IO Proteome Atlas (IPA) is […]

COLOGNE, Germany — Singleron has announced the launch of its AccuraCode® TCR library construction kit for high-throughput T-cell receptor (TCR) profiling. It enables simultaneous analysis of hundreds of samples for T cell clonotypes, gene usage, V(D)J recombination patterns, and diversity, all supported by compatible bioinformatics pipelines. The product is built upon Singleron’s molecular barcoding technology, enabling multiplexing […]

The SOPHiA DDM™ Platform will help Laboratorio Curie advance its research into BRCA gene mutations BOSTON and ROLLE, Switzerland — Sophia Genetics (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, has expanded its relationship with Laboratorio Curie, a leading laboratory located in the capital city of Paraguay. Laboratorio Curie is now live on the SOPHiA DDM™ Platform […]

Cambridge – Congenica, a leading digital health company specialising in the provision of software and solutions for genomic data analysis and interpretation, and myTomorrows, a global platform facilitating access to pre-approval treatments and clinical trials, have partnered to expedite access to precision oncology for cancer patients worldwide. The partnership between Congenica and myTomorrows will open […]

Cape Town, South Africa – MGI, a company committed to building core tools and technology to lead life science, is delighted to support The African BioGenome Project (AfricaBP), launched in 2021, in sequencing of the project’s first plant species based on MGI’s DNBSEQ-G400* versatile benchtop sequencer and single-tube long fragment read (stLFR) technology. An affiliated […]

Veenendaal, the Netherlands – MolGen, a global solutions provider of innovative DNA/RNA extraction and lab automation, has appointed Hayden Jeffreys as Global Vice President of Sales & Marketing. Mr Jeffreys has held a variety of C-suite roles from his most recent position as COO of AIM listed Yourgene Health plc and President of Yourgene Health Inc. […]

CHEONAN, South Korea — MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. (“BMS”) to expand genomics solutions in South Korea by leveraging MGI’s cutting-edge technology. The MOU is expected to reach collaborations in localizing MGI’s manufacturing capability in selected genetic sequencers and reagents in South Korea via […]

As a part of the National Institute of Standards and Technology (NIST) Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products DURHAM, N.C. — BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, today announced […]

BOSTON — Curiox Biosystems, a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, is pleased to announce its collaboration with Dr. Marco Ruella, an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn), to support efforts in the development of next-generation cancer cell therapies. The collaboration will […]